Detalhe da pesquisa
1.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438627
2.
The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission.
Haematologica
; 106(1): 111-122, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001529
3.
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome.
Br J Haematol
; 187(3): 337-346, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271217
4.
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
Haematologica
; 104(6): 1150-1155, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573507
5.
Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.
Haematologica
; 107(12): 2944-2949, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924576
6.
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Ann Hematol
; 96(3): 363-371, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011984
7.
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia.
Am J Hematol
; 97(8): E296-E298, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35604243
8.
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(4): 723-730, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26718666
9.
ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?
Am J Hematol
; 90(1): 37-41, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293449
10.
CML stem cells: evasion for better invasion.
Blood
; 129(2): 141-142, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082292
11.
Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy.
Haematologica
; 99(3): 458-64, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362549
12.
[Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)]. / Optimisation du bosutinib dans la leucémie myéloïde chronique : recommandations du Fi-LMC (France Intergroupe des leucémies myéloïdes chroniques).
Bull Cancer
; 111(1): 87-96, 2024 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-38087729
13.
Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.
Cancer
; 119(24): 4284-9, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105694
14.
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.
Cancer
; 119(1): 107-14, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22744794
15.
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
N Engl J Med
; 363(26): 2511-21, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21175313
16.
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study.
Blood
; 118(16): 4331-7, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849485
17.
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias.
Blood
; 118(20): 5697-700, 2011 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21926354
18.
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia.
Expert Rev Hematol
; 16(9): 633-639, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37427999
19.
A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation.
Cancers (Basel)
; 15(16)2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627189
20.
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Leuk Res
; 130: 107308, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230027